Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2020

11.10.2019 | Editorial

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

verfasst von: Kassandra P. Nealon, Nikhil Sobti, Michele Gadd, Michelle Specht, Eric C. Liao

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

There has been a sharp rise in the rate of contralateral prophylactic mastectomy over the last decade, despite the low incidence of new primary cancers predicted for the contralateral breast. This study compares the postoperative complication rates between the diseased breast treated with mastectomy and the contralateral breast that underwent prophylactic mastectomy, followed by immediate bilateral breast implant reconstruction. We hypothesized that there will be no difference in postoperative outcomes between prophylactic and diseased groups, as the surgical approach would be comparable.

Methods

After IRB approval, a retrospective chart review identified consecutive unilateral breast cancer patients who underwent bilateral mastectomy and immediate breast reconstruction between May 2008 and May 2018 at a tertiary academic medical center. A paired sample t-test and a penalized logic regression model were constructed to identify relationships between breast laterality and outcomes.

Results

A total of 1117 patients with unilateral breast cancer who underwent bilateral mastectomy and immediate breast implant reconstruction were identified. Rates of capsular contracture and infection were significantly greater in the diseased breast, while rates of revision were significantly greater in the contralateral prophylactic breast. There were no statistically significant differences between breasts in rates of explant, skin flap necrosis or hematoma. When adjusted for confounding variables, a higher infection rate was observed in the diseased breast.

Conclusion

This study detected significant differences in postoperative complication rates between the diseased and prophylactic breasts following bilateral mastectomy and immediate breast implant reconstruction. Postoperative complications occurred more frequently in the diseased breast compared with low rates of complications in the contralateral prophylactic breast. This information is helpful for preoperative decision making, as surgeons and patients carefully weigh the additional risks of contralateral prophylactic procedure.
Literatur
1.
Zurück zum Zitat Surgeons ASoP (2017) Plastic surgery statistics reports. American Society of Plastic Surgeons Surgeons ASoP (2017) Plastic surgery statistics reports. American Society of Plastic Surgeons
2.
Zurück zum Zitat Marmor RA, Dai W, Jiang X, Wang S, Blair SL, Huh J (2017) Increase in contralateral prophylactic mastectomy conversation online unrelated to decision-making. J Surg Res 218:253–260PubMedPubMedCentral Marmor RA, Dai W, Jiang X, Wang S, Blair SL, Huh J (2017) Increase in contralateral prophylactic mastectomy conversation online unrelated to decision-making. J Surg Res 218:253–260PubMedPubMedCentral
3.
Zurück zum Zitat Venetis M, MacGeorge E, Baptiste D, Mouton A, Friley L, Pastor R, Hatten K, Lagoo J, Bowling M, Clare S (2018) Social network, surgeon, and media influence on the decision to undergo contralateral prophylactic mastectomy. Am J Clin Oncol 41:519–525PubMed Venetis M, MacGeorge E, Baptiste D, Mouton A, Friley L, Pastor R, Hatten K, Lagoo J, Bowling M, Clare S (2018) Social network, surgeon, and media influence on the decision to undergo contralateral prophylactic mastectomy. Am J Clin Oncol 41:519–525PubMed
4.
Zurück zum Zitat Monticciolo DL, Newell M, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles E (2017) Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol 14:1137–1143PubMed Monticciolo DL, Newell M, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles E (2017) Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol 14:1137–1143PubMed
5.
Zurück zum Zitat Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, Charara R, Allen C, Naghavi M, Murray CJ (2017) Trends and patterns of disparities in cancer mortality among US counties, 1980–2014. JAMA 317:3880406 Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, Charara R, Allen C, Naghavi M, Murray CJ (2017) Trends and patterns of disparities in cancer mortality among US counties, 1980–2014. JAMA 317:3880406
6.
Zurück zum Zitat McLaughlin CC, Lillquist PP, Edge SB (2009) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412PubMed McLaughlin CC, Lillquist PP, Edge SB (2009) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412PubMed
7.
Zurück zum Zitat Wood W (2008) Increasing use of contralateral prophylactic mastectomy: a counterintuitive trend. Oncology 22:545–551 Wood W (2008) Increasing use of contralateral prophylactic mastectomy: a counterintuitive trend. Oncology 22:545–551
8.
Zurück zum Zitat Frost MH, Slezak J, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23:7849–7856PubMed Frost MH, Slezak J, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23:7849–7856PubMed
9.
Zurück zum Zitat Tuttle TM, Habermann E, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209PubMed Tuttle TM, Habermann E, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209PubMed
10.
Zurück zum Zitat Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367PubMed Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367PubMed
11.
Zurück zum Zitat Yao K, Stewart A, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 10:2554–2562 Yao K, Stewart A, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 10:2554–2562
12.
Zurück zum Zitat Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K (2003) Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. J Am Coll Surg 1:19–28 Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K (2003) Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. J Am Coll Surg 1:19–28
13.
Zurück zum Zitat Stucky CC, Gray R, Wasif N, Dueck AC, Pockaj BA (2010) Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol 17:330–337PubMed Stucky CC, Gray R, Wasif N, Dueck AC, Pockaj BA (2010) Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol 17:330–337PubMed
14.
Zurück zum Zitat Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, Nelson J (2011) Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg 201:615–618PubMed Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, Nelson J (2011) Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg 201:615–618PubMed
15.
Zurück zum Zitat Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D (2013) Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol 36:275–380 Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D (2013) Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol 36:275–380
16.
Zurück zum Zitat McGuire KP, Santillan A, Kaur P, Meade T, Parbhoo J, Mathias M, Shamehdi C, Davis M, Ramos D, Cox CE (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682–2690PubMed McGuire KP, Santillan A, Kaur P, Meade T, Parbhoo J, Mathias M, Shamehdi C, Davis M, Ramos D, Cox CE (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682–2690PubMed
17.
Zurück zum Zitat Arrington AK, Jarosek S, Virnig BA, Habermann EB, Tuttle TM (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697–2704PubMed Arrington AK, Jarosek S, Virnig BA, Habermann EB, Tuttle TM (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697–2704PubMed
18.
Zurück zum Zitat Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696PubMed Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696PubMed
19.
Zurück zum Zitat Hooper R, Hsu J, Duncan A, Bensenhaver J, Newman L, Kidwell K, Chung K, Momoh A (2019) Breast cancer knowledge and decisions made for contralateral prophylactic mastectomy: a survey of surgeons and women in the general population. Plast Reconstr Surg 143:936–945 Hooper R, Hsu J, Duncan A, Bensenhaver J, Newman L, Kidwell K, Chung K, Momoh A (2019) Breast cancer knowledge and decisions made for contralateral prophylactic mastectomy: a survey of surgeons and women in the general population. Plast Reconstr Surg 143:936–945
20.
Zurück zum Zitat Cemal Y, Albornoz CR, Disa JJ et al (2013) A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 131:320e–326ePubMed Cemal Y, Albornoz CR, Disa JJ et al (2013) A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 131:320e–326ePubMed
21.
Zurück zum Zitat Albornoz CR, Matros E, Lee CN et al (2015) Bilateral mastectomy versus breast-conserving surgery for early-stage breast cancer: the role of breast reconstruction. Plast Reconstr Surg 135:1518–1526PubMedPubMedCentral Albornoz CR, Matros E, Lee CN et al (2015) Bilateral mastectomy versus breast-conserving surgery for early-stage breast cancer: the role of breast reconstruction. Plast Reconstr Surg 135:1518–1526PubMedPubMedCentral
22.
Zurück zum Zitat Mutter RW, Frost M, Hoskin TL, Johnson JL, Hartmann LC, Boughey JC (2015) Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes. Breast Cancer Res Treat 153:183–190PubMed Mutter RW, Frost M, Hoskin TL, Johnson JL, Hartmann LC, Boughey JC (2015) Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes. Breast Cancer Res Treat 153:183–190PubMed
23.
Zurück zum Zitat Rebbeck TRFT, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055–1062PubMed Rebbeck TRFT, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055–1062PubMed
24.
Zurück zum Zitat Hartmann LCSD, Schaid D, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77–84PubMed Hartmann LCSD, Schaid D, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77–84PubMed
25.
Zurück zum Zitat McDonnell SK, Schaid D, Myers JL, Grant CS, Donohue JH, Woods JE, Frost MH, Johnson JL, Sitta DL, Slezak JM, Crotty TB, Jenkins RB, Sellers TA, Hartmann LC (2001) Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19:3938–3943PubMed McDonnell SK, Schaid D, Myers JL, Grant CS, Donohue JH, Woods JE, Frost MH, Johnson JL, Sitta DL, Slezak JM, Crotty TB, Jenkins RB, Sellers TA, Hartmann LC (2001) Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19:3938–3943PubMed
26.
Zurück zum Zitat van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJTH, van’t Veer LJ, Tollenaar RAEM (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287–292PubMedPubMedCentral van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJTH, van’t Veer LJ, Tollenaar RAEM (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287–292PubMedPubMedCentral
27.
Zurück zum Zitat Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159–164PubMed Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159–164PubMed
28.
Zurück zum Zitat Kurian AW, Lichtensztajn D, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA 312:902–914PubMedPubMedCentral Kurian AW, Lichtensztajn D, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA 312:902–914PubMedPubMedCentral
29.
Zurück zum Zitat Bedrosian I, Yu C, Chang GJ (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:401–409PubMedPubMedCentral Bedrosian I, Yu C, Chang GJ (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:401–409PubMedPubMedCentral
31.
Zurück zum Zitat Yao K, Winchester D, Czechura T, Huo D (2013) Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002. Breast Cancer Res Treat 142:465–467PubMed Yao K, Winchester D, Czechura T, Huo D (2013) Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002. Breast Cancer Res Treat 142:465–467PubMed
32.
Zurück zum Zitat Yu TJ, Liu Y, Hu X, Di GH (2018) No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma. J Surg Oncol 118:928–935PubMed Yu TJ, Liu Y, Hu X, Di GH (2018) No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma. J Surg Oncol 118:928–935PubMed
33.
Zurück zum Zitat Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275–4286PubMed Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275–4286PubMed
34.
Zurück zum Zitat Katz SJ, Morrow M (2013) Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA 310:793–794PubMed Katz SJ, Morrow M (2013) Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA 310:793–794PubMed
35.
Zurück zum Zitat Wong SM, Freedman R, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265:581–589PubMed Wong SM, Freedman R, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265:581–589PubMed
36.
Zurück zum Zitat Momoh AO, Cohen W, Kidwell KM, Hamill JB, Qi J, Pusic AL, Wilkins EG, Matros E (2017) Tradeoffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction: results of a prospective multicenter cohort. Ann Surg 266:158–164PubMedPubMedCentral Momoh AO, Cohen W, Kidwell KM, Hamill JB, Qi J, Pusic AL, Wilkins EG, Matros E (2017) Tradeoffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction: results of a prospective multicenter cohort. Ann Surg 266:158–164PubMedPubMedCentral
37.
Zurück zum Zitat Geiger AM, West C, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW (2006) Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 24:1350–1356PubMed Geiger AM, West C, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW (2006) Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 24:1350–1356PubMed
38.
Zurück zum Zitat Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Linden A, von Wachenfeldt A, Wickman M, Arver B (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26:3943–3949PubMed Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Linden A, von Wachenfeldt A, Wickman M, Arver B (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26:3943–3949PubMed
39.
Zurück zum Zitat Boughey J, Attai D, Chen S, Cody H, Dietz J, Feldman S, Greenberg C, Kass R, Landercasper J, Lemaine V, MacNeill F, Song D, Staley A, Wilke L, Willey S, Yao K, Margenthaler J (2016) Contralateral prophylactic mastectomy (CPM) consensus statement from the american society of breast surgeons: data on CPM outcomes and risks. Ann Surg Oncol 23:3100–3105PubMedPubMedCentral Boughey J, Attai D, Chen S, Cody H, Dietz J, Feldman S, Greenberg C, Kass R, Landercasper J, Lemaine V, MacNeill F, Song D, Staley A, Wilke L, Willey S, Yao K, Margenthaler J (2016) Contralateral prophylactic mastectomy (CPM) consensus statement from the american society of breast surgeons: data on CPM outcomes and risks. Ann Surg Oncol 23:3100–3105PubMedPubMedCentral
40.
Zurück zum Zitat Buchanan PJ, Abdulghani M, Waljee JF, Kozlow JH, Sabel MS, Newman LA, Chung KC, Momoh AO (2016) An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg 138:29–40PubMed Buchanan PJ, Abdulghani M, Waljee JF, Kozlow JH, Sabel MS, Newman LA, Chung KC, Momoh AO (2016) An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg 138:29–40PubMed
41.
Zurück zum Zitat Huang J, Chagpar A (2018) Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy. Am J Surg 218:170–174PubMed Huang J, Chagpar A (2018) Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy. Am J Surg 218:170–174PubMed
42.
Zurück zum Zitat Parker P, Peterson S, Shen Y, Bedrosian I, Black D, Thompson A (2018) Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol 36:2630–2638PubMedPubMedCentral Parker P, Peterson S, Shen Y, Bedrosian I, Black D, Thompson A (2018) Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol 36:2630–2638PubMedPubMedCentral
43.
Zurück zum Zitat Manne S, Smith B, Mitarotondo A, Frederick S, Toppmeyer D, Kirstein L (2018) Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy. Patient Educ Couns 102:902–908PubMed Manne S, Smith B, Mitarotondo A, Frederick S, Toppmeyer D, Kirstein L (2018) Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy. Patient Educ Couns 102:902–908PubMed
44.
Zurück zum Zitat Hawley ST, Jagsi R, Morrow M et al (2014) Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg 149:582–589PubMedPubMedCentral Hawley ST, Jagsi R, Morrow M et al (2014) Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg 149:582–589PubMedPubMedCentral
45.
Zurück zum Zitat Soran A, Ibrahim A, Kanbour M et al (2015) Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer. Am J Clin Oncol 38:179–183PubMed Soran A, Ibrahim A, Kanbour M et al (2015) Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer. Am J Clin Oncol 38:179–183PubMed
46.
Zurück zum Zitat Rosenberg STM, Meyer M, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come S, Winer E, Partridge A (2014) Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med 159:373–381 Rosenberg STM, Meyer M, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come S, Winer E, Partridge A (2014) Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med 159:373–381
47.
Zurück zum Zitat Hoskin TLHT, Degnim AC, Jakub JW, Jacobson SR, Boughey JC (2016) Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery 159:1199–1209PubMed Hoskin TLHT, Degnim AC, Jakub JW, Jacobson SR, Boughey JC (2016) Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery 159:1199–1209PubMed
48.
Zurück zum Zitat Silva AKLB, Yao KA, Song DH, Sisco M (2015) The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol 22:3474–3480PubMed Silva AKLB, Yao KA, Song DH, Sisco M (2015) The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol 22:3474–3480PubMed
49.
Zurück zum Zitat Crosby MAGP, Selber JC, Adelman DM, Sacks JM, Villa MT, Lin HY, Park SJ, Baumann DP (2011) Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy. Plast Reconstr Surg 128:1025–1033PubMed Crosby MAGP, Selber JC, Adelman DM, Sacks JM, Villa MT, Lin HY, Park SJ, Baumann DP (2011) Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy. Plast Reconstr Surg 128:1025–1033PubMed
50.
Zurück zum Zitat Huang JCA (2018) Complications in patients with unilateral breast cancer who undergo contralateral prophylactic mastectomy versus unilateral mastectomy. Surgery 164:1347–1350PubMed Huang JCA (2018) Complications in patients with unilateral breast cancer who undergo contralateral prophylactic mastectomy versus unilateral mastectomy. Surgery 164:1347–1350PubMed
51.
Zurück zum Zitat Alba B, Schultz BD, Cohen D, Qin AL, Chan W, Tanna N (2019) Risk-to-benefit relationship of contralateral prophylactic mastectomy: the argument for bilateral mastectomies with immediate reconstruction. Plast Reconstr Surg 144:1–9PubMed Alba B, Schultz BD, Cohen D, Qin AL, Chan W, Tanna N (2019) Risk-to-benefit relationship of contralateral prophylactic mastectomy: the argument for bilateral mastectomies with immediate reconstruction. Plast Reconstr Surg 144:1–9PubMed
52.
Zurück zum Zitat Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 20:3212–3217PubMed Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 20:3212–3217PubMed
53.
Zurück zum Zitat Kobraei ECR, Gadd M, Austen W, Liao EC (2016) Avoiding breast animation deformity with pectoralis-sparing subcutaneous direct-to-implant breast reconstruction. Plast Reconstr Surg Glob Open 4:708 Kobraei ECR, Gadd M, Austen W, Liao EC (2016) Avoiding breast animation deformity with pectoralis-sparing subcutaneous direct-to-implant breast reconstruction. Plast Reconstr Surg Glob Open 4:708
54.
Zurück zum Zitat Colwell ASCJ (2017) Nipple-sparing mastectomy and direct-to-implant breast reconstruction. Plast Reconstr Surg 140:44S–50SPubMed Colwell ASCJ (2017) Nipple-sparing mastectomy and direct-to-implant breast reconstruction. Plast Reconstr Surg 140:44S–50SPubMed
55.
Zurück zum Zitat As C (2012) Direct-to-implant breast reconstruction. Gland Surg 1:139–141 As C (2012) Direct-to-implant breast reconstruction. Gland Surg 1:139–141
56.
Zurück zum Zitat LE Gfrerer L (2018) Technique refinement in prepectoral implant based reconstruction with vicryl mesh pocket and acellular dermal matrix support. Plast Reconstr Surg Glob Open 6:1749 LE Gfrerer L (2018) Technique refinement in prepectoral implant based reconstruction with vicryl mesh pocket and acellular dermal matrix support. Plast Reconstr Surg Glob Open 6:1749
58.
Zurück zum Zitat Cancer Stat Facts: Female Breast Cancer US Department of Health and Human Services, National Institute of Health, National Cancer Institute Cancer Stat Facts: Female Breast Cancer US Department of Health and Human Services, National Institute of Health, National Cancer Institute
59.
Zurück zum Zitat Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMed Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMed
61.
Zurück zum Zitat Ricceri F, Fasanelli F, Giraudo MT et al (2015) Risk of second primary malignancies in women with breast cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 137:940–948PubMed Ricceri F, Fasanelli F, Giraudo MT et al (2015) Risk of second primary malignancies in women with breast cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 137:940–948PubMed
62.
Zurück zum Zitat Abbott ARN, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129–3136PubMed Abbott ARN, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129–3136PubMed
63.
Zurück zum Zitat Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG (1984) Second primary cancers of the breast: incidence and risk factors. Br J Cancer 49:79–85PubMedPubMedCentral Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG (1984) Second primary cancers of the breast: incidence and risk factors. Br J Cancer 49:79–85PubMedPubMedCentral
64.
Zurück zum Zitat Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE (1997) Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 4:198–202PubMed Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE (1997) Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 4:198–202PubMed
65.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105:195–207PubMed Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105:195–207PubMed
66.
Zurück zum Zitat Miller MEMS, Olcese C, Patil S, Morrow M, Van Zee KJ (2017) Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy? Ann Surg Oncol 24:2889–2897PubMedPubMedCentral Miller MEMS, Olcese C, Patil S, Morrow M, Van Zee KJ (2017) Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy? Ann Surg Oncol 24:2889–2897PubMedPubMedCentral
67.
Zurück zum Zitat Wärnberg FGH, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol 32:3613–3618PubMed Wärnberg FGH, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol 32:3613–3618PubMed
68.
Zurück zum Zitat Falk RSHS, Skaane P, Haldorsen T (2011) Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat 129:929–938PubMed Falk RSHS, Skaane P, Haldorsen T (2011) Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat 129:929–938PubMed
69.
Zurück zum Zitat Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 10:5887–5892 Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 10:5887–5892
70.
Zurück zum Zitat Schmidt MK, Hogervorst F, van Hien R et al (2016) Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. J Clin Oncol 34:2750–2760PubMedPubMedCentral Schmidt MK, Hogervorst F, van Hien R et al (2016) Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. J Clin Oncol 34:2750–2760PubMedPubMedCentral
71.
Zurück zum Zitat van der Kolk DM, de Bock G, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124:643–651PubMed van der Kolk DM, de Bock G, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124:643–651PubMed
72.
Zurück zum Zitat Nichols HB, de González AB, Lacey JV Jr, Rosenberg PS, Anderson WF (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 20:1564–1569 Nichols HB, de González AB, Lacey JV Jr, Rosenberg PS, Anderson WF (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 20:1564–1569
73.
Zurück zum Zitat van den Broek AJ, van’t Veer L, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, van Beek M, Janssen-Heijnen ML, Seynaeve C, Westenend PJ, Jobsen JJ, Siesling S, Tollenaar RA, van Leeuwen FE, Schmidt MK (2016) Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers. J Clin Oncol 34:409–418PubMed van den Broek AJ, van’t Veer L, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, van Beek M, Janssen-Heijnen ML, Seynaeve C, Westenend PJ, Jobsen JJ, Siesling S, Tollenaar RA, van Leeuwen FE, Schmidt MK (2016) Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers. J Clin Oncol 34:409–418PubMed
74.
Zurück zum Zitat Hatcher MFL (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322:76PubMedPubMedCentral Hatcher MFL (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322:76PubMedPubMedCentral
75.
Zurück zum Zitat Nelson JATJ, Domchek S, Sonnad SS, Serletti JM, Wu LC (2012) Breast reconstruction in bilateral prophylactic mastectomy patients: factors that influence decision making. J Plast Reconstr Aesthet Surg 65:1481–1489PubMed Nelson JATJ, Domchek S, Sonnad SS, Serletti JM, Wu LC (2012) Breast reconstruction in bilateral prophylactic mastectomy patients: factors that influence decision making. J Plast Reconstr Aesthet Surg 65:1481–1489PubMed
76.
Zurück zum Zitat Cheng H, Chen B-H, Soleas IM, Ferko NC, Cameron CG, Hinoul P (2017) Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect 18:722–735 Cheng H, Chen B-H, Soleas IM, Ferko NC, Cameron CG, Hinoul P (2017) Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect 18:722–735
77.
Zurück zum Zitat Korol EJK, Waser N et al (2013) A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS ONE 8:e83743PubMedPubMedCentral Korol EJK, Waser N et al (2013) A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS ONE 8:e83743PubMedPubMedCentral
78.
Zurück zum Zitat Wg C (2006) Risk factors for surgical site infection. Surg Infect 7:7–11 Wg C (2006) Risk factors for surgical site infection. Surg Infect 7:7–11
79.
Zurück zum Zitat Lucci AML, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663 Lucci AML, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663
80.
Zurück zum Zitat Behranwala KA, Dua R, Ross GM, Ward A, A’hern R, Gui GP (2006) The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 59:1043–1051PubMed Behranwala KA, Dua R, Ross GM, Ward A, A’hern R, Gui GP (2006) The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 59:1043–1051PubMed
81.
Zurück zum Zitat Spear SLOC (2000) Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 105:930–942PubMed Spear SLOC (2000) Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 105:930–942PubMed
82.
Zurück zum Zitat Cordeiro PGPA, Disa JJ, McCormick B, VanZee K (2004) Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 113:877–881PubMed Cordeiro PGPA, Disa JJ, McCormick B, VanZee K (2004) Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 113:877–881PubMed
83.
Zurück zum Zitat Krueger EAWE, Strawderman M, Cederna P, Goldfarb S, Vicini FA, Pierce LJ (2001) Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol 49:713–721 Krueger EAWE, Strawderman M, Cederna P, Goldfarb S, Vicini FA, Pierce LJ (2001) Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol 49:713–721
84.
Zurück zum Zitat Garvey EMGR, Wasif N, Casey WJ, Rebecca AM, Kreymerman P, Bash D, Pockaj BA (2014) Neoadjuvant therapy and breast cancer surgery a closer look at postoperative complications. Am J Surg 206:894–898 Garvey EMGR, Wasif N, Casey WJ, Rebecca AM, Kreymerman P, Bash D, Pockaj BA (2014) Neoadjuvant therapy and breast cancer surgery a closer look at postoperative complications. Am J Surg 206:894–898
85.
Zurück zum Zitat Colwell ASDB, Zahedi B, Medford-Davis L, Hertl C, Austen WG Jr (2011) Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 128:1170–1178PubMed Colwell ASDB, Zahedi B, Medford-Davis L, Hertl C, Austen WG Jr (2011) Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 128:1170–1178PubMed
86.
Zurück zum Zitat Katz SJ, Hawley ST, Hamilton AS et al (2018) Surgeon influence on variation in receipt of contralateral prophylactic mastectomy for women with breast cancer. JAMA Surg 153:29–36PubMed Katz SJ, Hawley ST, Hamilton AS et al (2018) Surgeon influence on variation in receipt of contralateral prophylactic mastectomy for women with breast cancer. JAMA Surg 153:29–36PubMed
87.
Zurück zum Zitat NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction. National Comprehensive Cancer Network (NCCN), 2018 NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction. National Comprehensive Cancer Network (NCCN), 2018
88.
Zurück zum Zitat Chung AHK, Lawrence C, Sim MS, Giuliano A (2012) Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol 19:2600–2606PubMed Chung AHK, Lawrence C, Sim MS, Giuliano A (2012) Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol 19:2600–2606PubMed
89.
Zurück zum Zitat Yi M, Hunt K, Arun B, Bedrosian I, Gutierrez Barrera A, Do KA, Kuerer H, Babiera G, Mittendorf E, Ready K, Litton J, Meric-Bernstam F (2015) Factors impacting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Preserv Res 3:1026–1034 Yi M, Hunt K, Arun B, Bedrosian I, Gutierrez Barrera A, Do KA, Kuerer H, Babiera G, Mittendorf E, Ready K, Litton J, Meric-Bernstam F (2015) Factors impacting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Preserv Res 3:1026–1034
90.
Zurück zum Zitat King TASR, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158–2164PubMed King TASR, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158–2164PubMed
91.
Zurück zum Zitat Koslow SPL, Scott AM, Stempel M, Morrow M, Pusic AL, King TA (2013) Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol 20:3422–3429PubMed Koslow SPL, Scott AM, Stempel M, Morrow M, Pusic AL, King TA (2013) Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol 20:3422–3429PubMed
92.
Zurück zum Zitat Rizzo AGE, Benacquista T, Draper L, Conejero AL, Weichman KE (2018) Abstract 71: postoperative quality of life in patients undergoing contralateral prophylactic mastectomy with breast reconstruction. Plast Reconstr Surg Glob Open 6:56–57PubMedCentral Rizzo AGE, Benacquista T, Draper L, Conejero AL, Weichman KE (2018) Abstract 71: postoperative quality of life in patients undergoing contralateral prophylactic mastectomy with breast reconstruction. Plast Reconstr Surg Glob Open 6:56–57PubMedCentral
93.
Zurück zum Zitat Jagsi R, Hawley ST, Griffith KA et al (2017) Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg 152:274–282PubMedPubMedCentral Jagsi R, Hawley ST, Griffith KA et al (2017) Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg 152:274–282PubMedPubMedCentral
94.
Zurück zum Zitat Agarwal SKK, Kraft CT et al (2015) Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg 135:661–670PubMedPubMedCentral Agarwal SKK, Kraft CT et al (2015) Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg 135:661–670PubMedPubMedCentral
Metadaten
Titel
Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction
verfasst von
Kassandra P. Nealon
Nikhil Sobti
Michele Gadd
Michelle Specht
Eric C. Liao
Publikationsdatum
11.10.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05460-0

Weitere Artikel der Ausgabe 2/2020

Breast Cancer Research and Treatment 2/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.